BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30900256)

  • 1. Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
    Panth N; Simpson MC; Sethi RKV; Varvares MA; Osazuwa-Peters N
    Laryngoscope; 2020 Feb; 130(2):385-391. PubMed ID: 30900256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
    Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes for head and neck patients with Medicaid: A health insurance paradox.
    Pannu JS; Simpson MC; Adjei Boakye E; Massa ST; Cass LM; Challapalli SD; Rohde RL; Osazuwa-Peters N
    Head Neck; 2021 Jul; 43(7):2136-2147. PubMed ID: 33780066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rising incidence of late-stage head and neck cancer in the United States.
    Thompson-Harvey A; Yetukuri M; Hansen AR; Simpson MC; Adjei Boakye E; Varvares MA; Osazuwa-Peters N
    Cancer; 2020 Mar; 126(5):1090-1101. PubMed ID: 31722124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in stage of presentation of head and neck cancer in the United States before and after the affordable care act.
    Panth N; Barnes JM; Simpson MC; Adjei Boakye E; Sethi RKV; Varvares MA; Osazuwa-Peters N
    Cancer Epidemiol; 2020 Aug; 67():101763. PubMed ID: 32593161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery.
    Rohlfing ML; Mays AC; Isom S; Waltonen JD
    Laryngoscope; 2017 Dec; 127(12):2784-2789. PubMed ID: 28639701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of health insurance status on the survival of patients with head and neck cancer.
    Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
    Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
    Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
    Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.
    Osazuwa-Peters N; Barnes JM; Megwalu U; Adjei Boakye E; Johnston KJ; Gaubatz ME; Johnson KJ; Panth N; Sethi RKV; Varvares MA
    Oral Oncol; 2020 Nov; 110():104870. PubMed ID: 32629408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER Database.
    Cannon RB; Shepherd HM; McCrary H; Carpenter PS; Buchmann LO; Hunt JP; Houlton JJ; Monroe MM
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1052-1057. PubMed ID: 30242321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
    Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and Neck Squamous Cell Carcinoma in Adolescents and Young Adults: Survivorship Patterns and Disparities.
    Challapalli SD; Simpson MC; Adjei Boakye E; Pannu JS; Costa DJ; Osazuwa-Peters N
    J Adolesc Young Adult Oncol; 2018 Aug; 7(4):472-479. PubMed ID: 29746178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Medicaid Expansion on Head and Neck Squamous Cell Carcinoma Presentation and Survival.
    Arch RS; Fei-Zhang DJ; Patel U; Rastatter JC
    Otolaryngol Head Neck Surg; 2024 Feb; 170(2):431-437. PubMed ID: 37811691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
    Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on the association between marital status and head and neck cancer outcomes.
    Simpson MC; Challapalli SD; Cass LM; Zahirsha ZS; Adjei Boakye E; Massa ST; Osazuwa-Peters N
    Oral Oncol; 2019 Feb; 89():48-55. PubMed ID: 30732958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance status and risk of cancer mortality among adolescents and young adults.
    Rosenberg AR; Kroon L; Chen L; Li CI; Jones B
    Cancer; 2015 Apr; 121(8):1279-86. PubMed ID: 25492559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States.
    Gaubatz ME; Bukatko AR; Simpson MC; Polednik KM; Adjei Boakye E; Varvares MA; Osazuwa-Peters N
    Oral Oncol; 2019 Feb; 89():95-101. PubMed ID: 30732966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
    Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
    J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.